IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 238 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $398,557 | +195.5% | 87,595 | +357.2% | 0.00% | – |
| Q2 2023 | $134,879 | -41.6% | 19,159 | +115.6% | 0.00% | – |
| Q2 2021 | $231,000 | -28.0% | 8,888 | +28.4% | 0.00% | -100.0% |
| Q4 2020 | $321,000 | +24.4% | 6,924 | -11.5% | 0.00% | 0.0% |
| Q3 2020 | $258,000 | +16.7% | 7,824 | -3.0% | 0.00% | 0.0% |
| Q2 2020 | $221,000 | -13.3% | 8,068 | -5.2% | 0.00% | 0.0% |
| Q1 2020 | $255,000 | -0.8% | 8,508 | -8.3% | 0.00% | 0.0% |
| Q4 2019 | $257,000 | +5.3% | 9,283 | -30.6% | 0.00% | 0.0% |
| Q3 2019 | $244,000 | -36.0% | 13,383 | -14.0% | 0.00% | 0.0% |
| Q2 2019 | $381,000 | – | 15,558 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MHR Fund Management | 11,997,103 | $84,459,605 | 11.88% |
| MPM BioImpact LLC | 2,950,118 | $20,768,831 | 4.18% |
| Perceptive Advisors | 14,036,410 | $98,816,326 | 2.86% |
| Velan Capital Investment Management LP | 240,000 | $1,689,600 | 1.57% |
| Parametrica Management Ltd | 96,500 | $679,360 | 1.31% |
| Boxer Capital, LLC | 3,705,133 | $26,084 | 1.21% |
| Soleus Capital Management, L.P. | 1,239,777 | $8,728,030 | 0.97% |
| Opaleye Management Inc. | 421,000 | $2,963,840 | 0.71% |
| 683 Capital Management, LLC | 1,400,000 | $9,856,000 | 0.71% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,758,759 | $12,381,665 | 0.70% |